Table 1.
Attribute | |
---|---|
Low molecular weight | Helps to ensure high levels of oral absorption, as well as reproducible interdosing exposure and pharmacokinetic profiles without the use of absorption enhancers |
Physical chemistry | Commensurate with desired absorption, distribution within the extracellular space, drug metabolism and drug elimination properties |
Chemical structure | Minimizes any undue drug metabolism of the drug in vivo |
Pharmacology | Selectivity for the pharmacological target vs non‐specific, or off‐target, activity |
Pharmacy | Formulation as a tablet as either the individual component or a constituent part of a fixed‐dose combination with commonly co‐administered agents (e.g. metformin, SGLT2i) |
Efficacy | Effective glucose lowering in comparison with alternative agents |
Potency | Effective glucose lowering at reasonable dose levels |
SGLT2i, sodium–glucose cotransporter‐2 inhibitor.